Create a psychologically safe environment where workers feel comfortable asking questions and demonstrating understanding.

Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...